MOS
ARCT icon

MGO One Seven’s Arcturus Therapeutics ARCT Stock Holding History

MGO One Seven’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-500
Closed -$8.48K – 865
2022
Q4 		$8.48K Buy
+500
New +$8.72K ﹤0.01% 734

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

MGO One Seven's ARCT Position: Q2 2026 in Review

MGO One Seven reduced its Arcturus Therapeutics (ARCT) stake by 7.6% in Q2 2026, selling an estimated $16K and leaving 24,788 shares worth $167K. The position accounts for ﹤0.01% of the portfolio, ranked #1496.

MGO One Seven first reported a position in ARCT in Q3 2019 and has held it in 28 quarters since. The position peaked at $1.3M in Q3 2021. 136 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • MGO One Seven held 24,788 shares of Arcturus Therapeutics worth $167K as of Q2 2026.
  • MGO One Seven sold 2,029 Arcturus Therapeutics shares in Q2 2026, an estimated $16K.
  • Arcturus Therapeutics made up ﹤0.01% of MGO One Seven's portfolio in Q2 2026, its #1496 holding.
  • MGO One Seven first reported a position in Arcturus Therapeutics in Q3 2019 and has held it in 28 quarters since.
  • MGO One Seven's Arcturus Therapeutics position peaked at $1.3M in Q3 2021.
  • 136 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.